Launch Of Wearable Drug Delivery Devices Opens New Opportunities For Self-Administration Of Medication

You have to be a patient to know how troublesome the drug treatment and therapeutics are. Moreover, it is incredibly frustrating to adapt according to the treatment schedule and that’s why millions of dollars are spent to design and develop effective and minimally-invasive drug delivery devices to help make patient’s lifeless painful than it already is. 

The ever-increasing prevalence of chronic disease and growth in the biologics market has increased the demand for drug delivery devices. According to Allied Market Research, the drug delivery devices market is expected to reach $26.74 billion by 2026, growing at a CAGR of 4.3% from 2019 to 2026.

Role of drug delivery devices

Thanks to advancements in drug delivery devices, more and more patients suffering from chronic illness choose to use home-use therapies such as wearable auto-injectors and prefilled syringes. This aids them to continue their treatment with fewer visits to their doctors. In addition, larger molecule biological drugs tend to be more viscous and may create challenges for drug delivery and possibly create pain on administration. If such treatments have to be administered frequently, the design of the drug plays a crucial part.

Now, when the entire world is dealing with the Covid-19 outbreak and the healthcare professionals are far too bust, people are encouraged to opt for self-administration within their houses and undergo treatment in a more relax and familiar setting. Thus, the user-friendliness of drug delivery devices is more important.

New launches in the industry

To ease the pain of the administration of drugs, several market players have unveiled their new drug delivery devices. For instance, Sorrel Medical, a manufacturer of wearable drug delivery devices, has launched its new manufacturing facility with the most innovative cleanroom facilities to improve the scalability of its wearable delivery devices.

This facility would improve its transition from initial design and development to scalable high-quality production of wearable drug delivery devices. The new facility includes an 80 square-meter cleanroom, which is expected to boost the initial production capacity to thousands of units every year.

Apart from this, Sorrel’s platform of pre-filled and pre-loaded wearable drug delivery devices enablesa simple and efficient way to self-administrate high viscosity medications. This device includes a primary container-agnostic configuration, which can easily accommodate a variety of industry-standard primary drug containers, smart sensing capabilities, and UV LED disinfection. This enables a precise administration.

The drug delivery design has gained a vital role in the healthcare industry, especially during this pandemic when healthcare professionals are busy dealing with Covid-19 patients and self-administration has become a necessity.This has created a profitable opportunity for the market players to improve their drug delivery devices and invest in developing wearable drug delivery devices. Apart from this, developing drug delivery devices could be profitable for manufacturers as well. It can help you extend the patent protection on a drug. Thus, it is safe to say that the drug delivery device market would witness a bright future if the devices become more and more supportive and easier for patients.

Related Post